Zantac Lawyer

Heartburn is a fairly common affliction characterized by a burning sensation in the chest. Studies indicate that more than 60 million Americans experience heartburn at least once a month. But, most of the time, dietary changes or nonprescription drugs can alleviate the discomfort. Many people would not think twice about the dangers of a drug used to remedy such an easily treatable condition. Yet, several people claim they developed cancer after taking the heartburn medication Zantac. Did you develop cancer after taking Zantac? Don’t wait, reach out today to speak with a Zantac lawyer at The Lake Law Firm. 

Our law firm is currently handling lawsuits on behalf of individuals who have taken Zantac to treat intestinal issues. Zantac contains a toxic and carcinogenic chemical, known as NDMA, which may increase the risk of certain cancers.

What Do We Know About Zantac Lawsuits?

Zantac is classified as a histamine-2 blocker that reduces the amount of acid the stomach produces. It is the brand name form of ranitidine. Consumers could receive Zantac over-the-counter (OTC) or through prescription. People took OTC ranitidine to prevent and relieve heartburn, while doctors prescribed ranitidine to treat ulcers in the stomach and intestinal ulcers or gastroesophageal reflux disease (GERD).

Carcinogens in Zantac 

In September 2019, FDA testing revealed low N-Nitrosodimethylamine (NDMA) levels. NDMA is an environmental contaminant sometimes found in food and water. The International Agency for Research on Cancer (IARC) classifies NDMA as a possible carcinogen, a substance capable of causing cancer. Further studies indicated that levels of NDMA in ranitidine increased in higher temperatures. An independent lab in California, Emery Pharma, found that heat and time contribute to higher levels of NDMA in Zantac. Therefore, NDMA levels can increase even after the medication is packaged and stored. These worrisome findings confirmed that the longer Zantac sits on the shelf, the greater the NDMA levels grow.

FDA Involvement

The FDA did not recall ranitidine products following the testing in 2019. Rather, the agency claimed the levels of NDMA found in ranitidine barely exceed those found in common foods. However, the FDA did mention that consumers could consider alternative medicines. 

In September 2019, manufacturers and pharmacies like CVS, Walmart, and Walgreens stopped the distribution of ranitidine drugs. 

On April 1, 2020, the FDA finally ordered the withdrawal of all Zantac and other ranitidine medications from the market. This recall applied to all OTC and prescription forms of ranitidine. Despite the warning in 2019, the FDA advised it did not have enough evidence to pull ranitidine products. However, the agency issued this order after discovering that NDMA levels can increase in Zantac even when stored at normal temperatures. The recall instructed all retailers, manufacturers, doctors, and people taking the drug (with a doctor’s assistance in stopping) to remove the drug or dispose of it.

Zantac Injuries

Scientific studies link NDMA-contaminated ranitidine to certain types of cancer. Scientists continue to research the side effects of ranitidine but have not determined an exact risk value yet. Prolonged exposure to high NDMA levels in ranitidine may cause:

  • Breast cancer
  • Stomach cancer
  • Bladder cancer
  • Intestinal cancer
  • Colorectal cancer
  • Prostate cancer
  • Pancreatic cancer
  • Leukemia
  • Non-Hodgkin’s lymphoma
  • Multiple myeloma

Zantac Lawsuits

Thousands of people have filed Zantac lawsuits nationwide. In February 2020, all federal Zantac lawsuits were consolidated into a multidistrict litigation (MDL). The judge overseeing these Zantac lawsuits ruled only brand-name Zantac cases will proceed. Also, the MDL will only focus on five types of cancer: bladder, liver, pancreatic, stomach, and esophageal. The first bellwether trial in MDL-2924 will begin in the summer of 2023. 

In August 2022, the first Zantac case scheduled for trial reached a $500,000 settlement shortly before trial. Plaintiff Joseph Bayer voluntarily dismissed his case due to a settlement he reached with generic drugmakers. Meanwhile, the first trial in a California Zantac class-action lawsuit and another state trial in Illinois are scheduled for February 2023.

Liability Law and Zantac

  • Zantac manufacturers may be liable for defectively designing Zantac because its active ingredient is unstable and unreasonably dangerous.
  • The manufacturers of Zantac did not issue prior warnings about the presence of NDMA in Zantac or disclose the risks of exposure to NDMA.

Can I Recover Compensation for My Injuries in a Zantac Lawsuit?

If you or a loved developed cancer after taking Zantac, you may recover compensation for any or all of the following:

  • Past and future medical expenses;
  • Past and future pain and suffering;
  • Loss of wages; and
  • Other economic losses related to your injury.

Millions of people took Zantac before warnings of its links to cancer surfaced. Lawsuits argue that Zantac manufacturers including GSK, Pfizer, and Boehringer Ingelheim, neglected to warn the public about the dangers of NDMA in their products. Despite growing evidence of NDMA levels increasing in Zantac products, these companies did not pull their products from the market. We understand that financial compensation cannot make amends for the irreversible damage to your health, but a lawsuit can hold manufacturers accountable for their reckless actions. Our Zantac lawyers are on standby to speak with you about your potential claim. 

How Our Law Firm Can Help You

The Lake Law Firm was founded by Edward J. Lake, Esq., a personal injury lawyer for over 25 years. Our dedicated team of attorneys is committed to seeking justice on behalf of those who have suffered injury or death due to the negligence of others. Our experienced attorneys handle many different types of pharmaceutical drugs, medical devices, and other defective products. The lawyers in our firm have helped collect millions of dollars for their clients. The Lake Law Firm will advocate for you and your rights. Please contact us for a free confidential case evaluation at (888) 274-0139 or submit an inquiry on this page.